180 Total Stockholder Equity from 2010 to 2024
| ATNF Stock | USD 2.38 0.15 6.73% |
Total Stockholder Equity | First Reported 2017-06-30 | Previous Quarter -418 K | Current Value 3.7 M | Quarterly Volatility 15.9 M |
Check 180 Life financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among 180 Life's main balance sheet or income statement drivers, such as Interest Expense of 42.59, Selling General Administrative of 6.4 M or Interest Income of 0.0, as well as many indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0 or Days Sales Outstanding of 0.0. 180 financial statements analysis is a perfect complement when working with 180 Life Valuation or Volatility modules.
180 | Total Stockholder Equity |
Latest 180 Life's Total Stockholder Equity Growth Pattern
Below is the plot of the Total Stockholder Equity of 180 Life Sciences over the last few years. It is the total equity held by shareholders, calculated as the difference between a company's total assets and total liabilities. It represents the net value of the company owned by shareholders. 180 Life's Total Stockholder Equity historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in 180 Life's overall financial position and show how it may be relating to other accounts over time.
| Total Stockholder Equity | 10 Years Trend |
|
Total Stockholder Equity |
| Timeline |
180 Total Stockholder Equity Regression Statistics
| Arithmetic Mean | 8,628,574 | |
| Geometric Mean | 379,507 | |
| Coefficient Of Variation | 170.02 | |
| Mean Deviation | 11,334,678 | |
| Median | 21,900 | |
| Standard Deviation | 14,670,714 | |
| Sample Variance | 215.2T | |
| Range | 39.5M | |
| R-Value | 0.42 | |
| Mean Square Error | 191.1T | |
| R-Squared | 0.18 | |
| Significance | 0.12 | |
| Slope | 1,374,228 | |
| Total Sum of Squares | 3013.2T |
180 Total Stockholder Equity History
About 180 Life Financial Statements
180 Life stakeholders use historical fundamental indicators, such as 180 Life's Total Stockholder Equity, to determine how well the company is positioned to perform in the future. Although 180 Life investors may analyze each financial statement separately, they are all interrelated. For example, changes in 180 Life's assets and liabilities are reflected in the revenues and expenses on 180 Life's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in 180 Life Sciences. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Total Stockholder Equity | -127.7 K | -121.3 K |
Currently Active Assets on Macroaxis
When determining whether 180 Life Sciences is a strong investment it is important to analyze 180 Life's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact 180 Life's future performance. For an informed investment choice regarding 180 Stock, refer to the following important reports:Check out the analysis of 180 Life Correlation against competitors. You can also try the Money Flow Index module to determine momentum by analyzing Money Flow Index and other technical indicators.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of 180 Life. If investors know 180 will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about 180 Life listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share 7.98 | Return On Assets (0.64) | Return On Equity (3.99) |
The market value of 180 Life Sciences is measured differently than its book value, which is the value of 180 that is recorded on the company's balance sheet. Investors also form their own opinion of 180 Life's value that differs from its market value or its book value, called intrinsic value, which is 180 Life's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because 180 Life's market value can be influenced by many factors that don't directly affect 180 Life's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between 180 Life's value and its price as these two are different measures arrived at by different means. Investors typically determine if 180 Life is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, 180 Life's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.